| II-39 Abdallah Derbalah Characterization of the hepatic distribution of oligonucleotide therapeutics using a cross-species biologics PBPK model Wednesday 15:35-17:00 |
| II-39 Abdallah Derbalah Characterization of the hepatic distribution of oligonucleotide therapeutics using a cross-species biologics PBPK model Wednesday 15:35-17:00 |